Cytomos Secures £5 Million Funding for Cell-Analysis Innovation
Cytomos, an innovative biotechnology company headquartered in Edinburgh, Scotland, has successfully secured £5 million in funding to advance its ambitious plans. This funding round was spearheaded by Archangels, a notable investor in early-stage companies, with additional contributions from Old College Capital, Scottish Enterprise, and the British Business Bank. The company is poised to utilize this capital to accelerate the sales of its inaugural commercial product, Celledonia™, which is founded on its proprietary cell-analysis technology platform known as AuraCyt. This groundbreaking product has already begun to gain considerable traction in the market, which bodes well for the future of the company.
Under the leadership of CEO David Rigterink, Cytomos is fully leveraging the capabilities of its AuraCyt platform, which represents a scalable solution for cell analysis that is designed to be more affordable than existing systems.
This technology is essential for biopharma companies that aim to expedite the development and market release of novel therapies while simultaneously minimizing costs. By providing a streamlined, cost-effective alternative, Cytomos is positioned to make a significant impact in the biotechnology sector, fulfilling a crucial need for efficiency in an industry that is often hampered by high expenditures and lengthy processes.
The company currently employs a team of 21 professionals who are largely based at its new facilities in Roslin. As Cytomos continues to grow and expand its operations, it anticipates hiring an additional four staff members over the next year. This expansion is indicative of the company's commitment to scaling its operations in response to increasing market demand. With a strong foundation and a clear vision for the future, Cytomos is on a path to not only enhance its technological offerings but also to make a lasting mark on the biopharmaceutical field.
They've invested in Cytomos
Get to know these Biotech investors
Click here for a full list of 6,481+ startup investors in the UK